Shane Devlin

2.6k citations

64 papers · 1.6k indexed · 1 hit paper · h-index 22

Impact in

Genetics top 2%
- Inflammatory Bowel Disease
Epidemiology top 5%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in ⓘ

Genetics 46
- Inflammatory Bowel Disease 45
Gastroenterology 8
- Celiac Disease Research and Management 4

Co-authors: Remo Panaccione (28 shared papers)Gilaad G. Kaplan (36 shared papers)Gil Melmed (17 shared papers)Brian Bressler (16 shared papers)Cynthia H. Seow (19 shared papers)Christopher N. Andrews (4 shared papers)Martin Storr (2 shared papers)Jennifer Jones (12 shared papers)
Journals: Inflammatory Bowel Diseases (7 papers)Clinical Gastroenterology and Hepatology (6 papers)Journal of Crohn s and Colitis (6 papers)Gastroenterology (6 papers)Alimentary Pharmacology & Therapeutics (4 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Shane Devlin

62 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases 2019 · 228 citations

Peers

Countries citing papers authored by Shane Devlin

Since Specialization

Citations

This map shows the geographic impact of Shane Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Devlin more than expected).

Fields of papers citing papers by Shane Devlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Devlin. The network helps show where Shane Devlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Shane Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shane Devlin Line = papers co-authored together Shane Devlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases Clinical Gastroenterology and Hepatology ·Konstantinos Papamichael, Adam S. Cheifetz, Gil Melmed, Peter M. Irving, Niels Vande Casteele, Patricia Kozuch, Laura E. Raffals, Leonard Baidoo, Brian Bressler, Shane Devlin, Jennifer Jones, Gilaad G. Kaplan, Miles Sparrow, Fernando Velayos, Thomas Ullman, Corey A. Siegel Hit paper breakdown →	2019	228
2	Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease Inflammatory Bowel Diseases ·Martin Storr, Shane Devlin, Gilaad G. Kaplan, Remo Panaccione, Christopher N. Andrews	2014	155
3	Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort Alimentary Pharmacology & Therapeutics ·Christopher Ma, Richard N. Fedorak, Gilaad G. Kaplan, Levinus A. Dieleman, Shane Devlin, N Stern, Karen I. Kroeker, Cynthia H. Seow, Yvette Leung, Kerri L. Novak, Brendan P. Halloran, Vivian Huang, Karen Wong, Philip K. Blustein, Subrata Ghosh, Remo Panaccione	2017	123
4	NOD2 Variants and Antibody Response to Microbial Antigens in Crohn’s Disease Patients and Their Unaffected Relatives Gastroenterology ·Shane Devlin, Huiying Yang, Andrew Ippoliti, Kent D. Taylor, Carol J. Landers, Xiaowen Su, María T. Abreu, Konstantinos A. Papadakis, Eric A. Vasiliauskas, Gil Melmed, Phillip Fleshner, Ling Mei, Jerome I. Rotter, Stephan R. Targan	2006	93
5	Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials Clinical Gastroenterology and Hepatology ·Jennifer Jones, Gilaad G. Kaplan, Laurent Peyrin‐Biroulet, Leonard Baidoo, Shane Devlin, Gil Melmed, Divine Tanyingoh, Laura E. Raffals, Peter M. Irving, Patricia Kozuch, Miles Sparrow, Fernando Velayos, Brian Bressler, Adam S. Cheifetz, Jean–Frédéric Colombel, Corey A. Siegel	2015	90
6	Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohnʼs Disease Inflammatory Bowel Diseases ·Christopher Ma, Richard N. Fedorak, Gilaad G. Kaplan, Levinus A. Dieleman, Shane Devlin, N Stern, Karen I. Kroeker, Cynthia H. Seow, Yvette Leung, Kerri L. Novak, Brendan P. Halloran, Vivian Huang, Karen Wong, Philip K. Blustein, Subrata Ghosh, Remo Panaccione	2017	81
7	Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy SHILAP Revista de lepidopterología ·Shane Devlin, Mark G. Swain, Stefan J. Urbanski, Kelly W. Burak	2004	80
8	Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Gordon W. Moran, Allen Lim, Jennifer Bailey, M Dubeau, Yvette Leung, Shane Devlin, Kerri L. Novak, Gilaad G. Kaplan, Marietta Iacucci, Cynthia H. Seow, L. Martin, Remo Panaccione, Subrata Ghosh	2013	51
9	Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada Canadian Journal of Gastroenterology and Hepatology ·Geoffrey C. Nguyen, Shane Devlin, Waqqas Afif, Brian Bressler, S E Gruchy, Gilaad G. Kaplan, Liliana Oliveira, Sophie Plamondon, Cynthia H. Seow, Chadwick Williams, Karen Wong, Brian Yan, Jennifer Jones	2014	45
10	Optimizing the safety of biologic therapy for IBD Nature Reviews Gastroenterology & Hepatology ·Shanika de Silva, Shane Devlin, Remo Panaccione	2010	42
11	Real‐world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Paulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi, Ahmed Al‐Darmaki, Shane Devlin, Gilaad G. Kaplan, Cynthia H. Seow, Kerri L. Novak, Cathy Lu, José G. Ferraz, Michael J. Stewart, Michelle Buresi, Humberto Jijon, M. Mathivanan, Joan Heatherington, Marie‐Louise Martin, Remo Panaccione	2018	42
12	Systematic review: the short‐term and long‐term efficacy of adalimumab following discontinuation of infliximab Alimentary Pharmacology & Therapeutics ·Christopher Ma, Remo Panaccione, Steven J. Heitman, Shane Devlin, Subrata Ghosh, Gilaad G. Kaplan	2009	41
13	The Appropriateness of Concomitant Immunomodulators With Anti–Tumor Necrosis Factor Agents for Crohn's Disease: One Size Does Not Fit All Clinical Gastroenterology and Hepatology ·Gil Melmed, Brennan Spiegel, Brian Bressler, Adam S. Cheifetz, Shane Devlin, Laura Harrell, Peter M. Irving, Jennifer Jones, Gilaad G. Kaplan, Patricia Kozuch, Fernando Velayos, Leonard Baidoo, Miles Sparrow, Corey A. Siegel	2010	39
14	Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study Journal of the Canadian Association of Gastroenterology ·Hang Hock Shim, Christopher Ma, Paulo Gustavo Kotze, Cynthia H. Seow, Heba Al-Farhan, Ahmed Al‐Darmaki, Jack Pang, Richard N. Fedorak, Shane Devlin, Levinus A. Dieleman, Gilaad G. Kaplan, Kerri L. Novak, Karen I. Kroeker, Brendan P. Halloran, Remo Panaccione	2018	33
15	Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up Medical Clinics of North America ·Shane Devlin, Remo Panaccione	2009	32
16	Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results Clinical Gastroenterology and Hepatology ·Gil Melmed, Peter M. Irving, Jennifer Jones, Gilaad G. Kaplan, Patricia Kozuch, Fernando Velayos, Leonard Baidoo, Miles Sparrow, Brian Bressler, Adam S. Cheifetz, Shane Devlin, Laura E. Raffals, Niels Vande Casteele, Diane R. Mould, Jean-Fred Colombel, Marla C. Dubinsky, William J. Sandborn, Corey A. Siegel	2016	27
17	Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics SHILAP Revista de lepidopterología ·Shane Devlin, Brian Bressler, Çharles N. Bernstein, Richard N. Fedorak, Alain Bitton, Harminder Singh, Brian G. Feagan	2013	27
18	Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease Digestive and Liver Disease ·L. Y. Kwan, Shane Devlin, James Mirocha, Konstantinos Papadakis	2008	26
19	Adalimumab for the treatment of Crohn's disease Expert Opinion on Biological Therapy ·Shane Devlin, Remo Panaccione	2008	24
20	Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up Gastroenterology Clinics of North America ·Shane Devlin, Remo Panaccione	2009	22

About Shane Devlin

Shane Devlin is a scholar working on Genetics, Gastroenterology, Epidemiology, Hematology and Immunology, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (45 papers), Microscopic Colitis (32 papers), Autoimmune and Inflammatory Disorders (13 papers), Diagnosis and treatment of tuberculosis (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Celiac Disease Research and Management (4 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Genetics (1.1k citations), Epidemiology (912 citations), Immunology (423 citations), Gastroenterology (103 citations) and Hepatology (99 citations). Shane Devlin has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Remo Panaccione, Gilaad G. Kaplan, Gil Melmed, Brian Bressler, Cynthia H. Seow, Christopher N. Andrews, Martin Storr, Jennifer Jones, Corey A. Siegel and Adam S. Cheifetz. Their work appears in journals such as Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology, Journal of Crohn s and Colitis, Gastroenterology and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact